Literature DB >> 7858972

Polyclonal antibodies and catalysis.

D B Stephens1, B H Wilmore, B L Iverson.   

Abstract

Some recent results involving catalytic polyclonal antibodies are described. Polyclonal antibodies isolated directly from serum contain the complete distribution of different IgG antibodies elicited via immunization, so catalytic results obtained with polyclonal antibodies can be used to characterize the overall catalytic activity produced in an animal in response to a given hapten. This new window on catalytic antibodies should be especially useful for identifying general trends relating hapten structure to antibody catalytic activity, for monitoring the maturation of catalytic activity during immunization, and for studying the variability of catalytic activity elicited in different animals immunized with the same hapten. Furthermore, studying the catalytic activity of polyclonal antibodies in serum may aid in the development of novel immunization-based therapies.

Mesh:

Substances:

Year:  1994        PMID: 7858972     DOI: 10.1016/0968-0896(94)85014-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  A general kinetic approach to investigation of active-site availability in macromolecular catalysts.

Authors:  M Resmini; S Gul; S Carter; S Sonkaria; C M Topham; G Gallacher; K Brocklehurst
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Polyclonal antibody catalytic variability.

Authors:  D B Stephens; R E Thomas; J F Stanton; B L Iverson
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

3.  Characterization of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg side chains as hydrogen-bond donors.

Authors:  M Resmini; R Vigna; C Simms; N J Barber; E P Hagi-Pavli; A B Watts; C Verma; G Gallacher; K Brocklehurst
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.